Alnylam Pharmaceuticals
ALNY
#565
Rank
S$48.59 B
Marketcap
$375.38
Share price
-3.35%
Change (1 day)
83.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company